hypocrellin a has been researched along with gambogic acid in 1 studies
Studies (hypocrellin a) | Trials (hypocrellin a) | Recent Studies (post-2010) (hypocrellin a) | Studies (gambogic acid) | Trials (gambogic acid) | Recent Studies (post-2010) (gambogic acid) |
---|---|---|---|---|---|
172 | 0 | 72 | 348 | 1 | 260 |
Protein | Taxonomy | hypocrellin a (IC50) | gambogic acid (IC50) |
---|---|---|---|
Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 3.07 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 0.47 | |
Regulator of G-protein signaling 17 | Homo sapiens (human) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
1 other study(ies) available for hypocrellin a and gambogic acid
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |